Article: Safeguard Scientifics Posts 2Q Financial Results

Safeguard Scientifics, a holding company for growth-stage life sciences and technology companies, announced second quarter results.

In a release dated August 5, the company stated:

- Net income from continuing operations attributable to Safeguard common shareholders in the second quarter was $146.2 million, or $1.20 per share, compared with a net loss of $7.5 million, or $0.06 per share, in the same period of 2008.

- Second quarter results reflect recognition of an unrealized gain in income from continuing operations of $106.0 million stemming from the deconsolidation of Safeguard's holdings in Clarient, and an additional gain of $52.5 million resulting from the mark-to-market of Safeguard's ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!